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XANTHINE OXIDASE 
INACTIVATION ATTENUATES 
POSTOCCLUSION SHOCK 
AFTER DESCENDING 
THORACIC AORTA 
OCCLUSION AND 
REPERFUSION IN RABBITS 
"Declamping shock" is observed after aortic crossclamping, with hypovo- 
lemia, hypotension, and metabolic acidemia invariably present. We hypoth- 
esized that oxidants derived from xanthine oxidase influence the resusci- 
tative interventions required to maintain baseline hemodynamic and 
acid-base status after aortic occlusion and reperfusion i  rabbits. We also 
hypothesized that inactivation of xanthine oxidase with sodium tungstate 
could reduce systemic injury as assessed by the release of lactate dehydro. 
genase and alkaline phosphatase. To test these hypotheses, we established 
aortic occlusion in rabbits (n = 10, standard iet; n = 8, tungstate diet) for 
40 minutes by inflation of a 4F Fogarty catheter in the descending thoracic 
aorta followed by 2 hours of reperfusion. Sham.operated rabbits (n = 10, 
standard diet; n = 9, tungstate diet) served as controls. Tungstate- 
pretreated rabbits required significantly less Ringer's solution (28%), 
phenylephrine (68%), and sodium bicarbonate (30%) during reperfusion 
(p < 0.005). Lactate dehydrogenase and alkaline phosphatase release 
during reperfusion was significantly attenuated by tungstate pretreatment 
(p < 0.05). Tungstate pretreatment resulted in plasma xanthine oxidase 
activities ignificantly lower than those in the sham group administered a 
standard iet (p = 0.007). Resuscitation requirements and systemic injury 
were reduced by inactivation of xanthine oxidase in a rabbit model that 
simulates the situation of human thoracic aorta operations. (J THORAC 
CARDIOVASC SURG 1995;110:715-22) 
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C ardiopulmonary, neurologic, and other organ 
injuries orten occur after an otherwise uncompli- 
cated descending thoracic aorta aneurysmectomy? 
When such complications occur, they are often 
associated with a high rate of permanent organ 
dysfunction and death. ~ Reperfused (for example, 
spinal cord) and remote (for example, lung) organs 
commonly develop tissue edema after aortic cross- 
clamping, a consequence of capillary membrane 
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compromise. Whereas risk factors for multiple or- 
gan dysfunction in this setting include patient age 1 
and concurrent organ dysfunction, 1'2 the role of 
oxidants in mediating systemic injury may be of 
critical importance during reperfusion. The preva- 
lence of paraplegia fter descending thoracic aorta 
crossclamping in a dog model was reduced by ad- 
ministration of the enzymatic antioxidant superox- 
ide dismutase (SOD). 3 Pulmonary oxidant injury 
was reduced by administration of the hydroxyl rad- 
ical scavenger mannitol during abdominal aortic 
aneurysm repair. 4 A more immediate concern after 
aortic crossclamping is the pathologic condition f 
' declamping shock. ''5-14 In addition to hypotension 
and hypovolemia, TM patients may incur a metabolic 
acidosis during reperfusion that is refractory to 
treatment for several hours, z2-14 Oxidants play an 
important role in "declamping shock" as demon- 
strated by Casthely and associates. 7 These investiga- 
tors reported an attenuation of the cardiovascular 
changes associated with descending thoracic aorta 
declamping in a dog model by infusion of SOD. The 
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hepatocellular enzyme xanthine oxidase (XO) may 
be a source of oxidants in the setting of descending 
thoracic aorta declamping. We have observed that 
the resultant hepatic and intestinal ischemia-reper- 
as ion  that occurs after thoracic aorta occlusion and 
repeffusion in a rabbit model causes the systemic 
release of XO. 15 
The present study tested the hypothesis that inac- 
tivation of XO with tungstate will reduce the pos- 
tocclusion shock associated with descending tho- 
racic aorta occlusion and reperfusion in rabbits. The 
determination of the resuscitative interventions 
(Ringer's solution, phenylephrine, and sodium bi- 
carbonate) required to maintain hemodynamic and 
acid-base status near preocclusion values during 
reperfusion served as a clinical assessment of pos- 
tocclusion shock. The release of the ubiquitous 
cytosolic enzymes lactate dehydrogenase (LDH) i6 
and alkaline phosphatase (ALP) 17 also served as a 
quantitative measure of systemic injury. 
Methods 
Surgieal protoeol. Male New Zealand white rabbits 
(Myrtle's Rabbits, Thompson Station, Tenn.) weighing 1.8 
to 2.5 kg were randomly administered a standard iet or a 
molybdenum-deficient, tungstate-enriched diet (0.07% 
sodium tungstate, Purina Mills, St. Louis, Mo.) for 10 days 
before experimentation. A 10-day feeding period with a 
tungstate-enriched diet markedly reduces tissue xanthine 
dehydrogenase (XDH) plus XO (XDH+XO) activities as 
determined by Johnson, Rajagopalan, and Cohen. TM Rab- 
bits were anesthetized with intravenous fentanyl (Elkins- 
Sinn, Inc., Cherry Hill, N.J.) 100 /~g/kg per hour and 
droperidol (American Reagent Laboratories, Shirley, 
N.Y.) 5 mg/kg per hour via a marginal ear vein. Arterial 
pressure was monitored by placement of a 22-gauge 
central ear artery catheter. After tracheostomy, mechan- 
ical ventilation (inspired oxygen fraction 1.0) with a 
Harvard Apparatus ventilator (model 661, Harvard Ap- 
paratus, Millis, Mass.) was done with arterial carbon 
dioxide tension maintained at 32 to 45 torr. Pancuronium 
bromide (Elkins-Sinn, Inc.) was administered at0.1 mg/kg 
per hour intravenously toensure relaxed chest wall muscle 
tone during ventilation. Central venous access was ob- 
tained via the right internal jugular rein with a 5F 
double-lumen catheter (Cook Critical Care, Bloomington, 
Ind.) for pressure monitoring and fluid administration. A 
right femoral arterial catheter was also placed to verify 
complete aortic occlusion in the aortic occlusion and 
repeffusion group. All rabbits received a maintenance 
infusion of Ringer's solution at 20 ml/kg per hour, and 
esophageal temperatures were maintained at 38 ° to 39 ° C 
with a heating pad. 
Sham-operated animals (standard iet, n = 10; tung- 
state diet, n = 9) had the left femoral artery exposed, with 
sham thoracic aorta occlusion beginning with ligation of 
that artery. The aortic occlusion and reperfusion group 
(standard diet, n = 10; tungstate diet, n = 8) also 
underwent a left femoral cutdown, with insertion of a 4F 
Fogarty embolectomy catheter (American Edwards Lab- 
oratory, Irvine, Calif.) into the thoracic aorta with the 
balloon placed 1 to 2 cm above the diaphragm. Balloon 
position was predetermined by measuring the distance 
between the surface anatomy landmarks of the xiphoid 
process and the inguinal igament. Catheter insertion to 
this length (usually 18 to 19 cm) at the inguinal igament 
placed the balloon at the appropriate site as confirmed by 
postmortem examination. Thoracic aorta occlusion was 
achieved by inflation of the catheter balloon with up to 
750 pJ of saline solution. Subdiaphragmatic is hemia was 
confirmed by continuous monitoring of the femoral arte- 
rial pressure, which measured 0 to 10 torr during balloon 
inflation. After 40 minutes of occlusion, the balloon was 
deflated and the catheter removed from the aorta. The 
ensuing postocclusion shock was treated according to the 
algorithms given in the resuscitation protocol section, 
which follows. Blood samples were removed before induc- 
tion of anesthesia, after 40 minutes of thoracic aorta 
occlusion, and at 5, 30, 60, and 120 minutes of reperfusion. 
Samples were taken from the ear or femoral artery. The 
blood was heparinized and centrifuged, with the plasma 
assayed as described in the biochemical nalysis section, 
which follows. After 2 hours of repeffusion, the rabbits 
were killed with an overdose of pentobarbital (The Butler 
Company, Columbus, Ohio) of 65 mg/kg given intrave- 
nously. 
Resuseitation protocol. Fluids and medications were 
administered with an Omni-Flow 4000 infusion pump 
system (Abbott Laboratories, North Chicago, Ill.). 
Ringer's solution administration. Administration of 
Ringer's olution was increased uring the last 20 minutes 
of aortic occlusion (120 tal/kg per hour). At the beginning 
of reperfusion, a bolus (20 ml/kg) was administered over 2 
minutes and the infusion rate adjusted to maintain central 
venous pressure at the preocclusion value _+ 1 mm Hg. The 
cumulative dosage of Ringer's olution (in milliliters per 
kilogram) was determined at 15, 30, 60, and 120 minutes 
of reperfusion. 
Phenylephrine administration. Phenylephrine (Elkins- 
Sinn, Inc.) administration began at reperfusion (10 mg/kg 
per hour) and was initially adjusted as follows: if the 
central venous pressure qualled the preocclusion value 
_+ 1 mm Hg and the mean arterial blood pressnre was less 
than 85% of the value before occlusion, phenylephrine 
was administered. The rate of administration was contin- 
uously adjusted throughout reperfusion to maintain mean 
arterial pressure within the target fange. The cumulative 
dosage of phenylephrine (in milligrams per kilogram) was 
determined at 15, 30, 60, and 120 minutes of reperfusion. 
Sodium bicarbonate administration. Sodium bicarbon- 
ate 8.4% (Abbott Laboratories) was infused intravenously 
at 7 mEq/kg per hour during the last 20 minutes of aortic 
occlusion. An additional 5 mEq/kg was injected at reper- 
fusion and the infusion continued at 7 mEq/kg per hour. 
The infusion of sodium bicarbonate was altered on the 
basis of arterial base excess (BE) changes as follows: if the 
BE was greater than 2, the infusion was decreased by 
50%; if BE was less than 2 or greater than -2, no change; 
if BE was less than -2  but greater than -5, the infusion 
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Fig. 1. Cumulative Ringer's solution requirement was significantly increased in aortic occlusion and 
reperfusion group administered standard iet (AoOR) as compared with that in aortic occlusion and 
reperfusion group pretreated with tungstate (AoOR + T). 
rate was increased 50%; if BE was less than -5,  the 
infusion rate was increased 50% and a 1 mEq/kg bolus was 
administered. The total dosage (in milliequivalents per 
kilogram per 2 hours of reperfusion) was determined. 
The study was approved by the Animal Review Com- 
mittee of the University of Alabama at Birmingham. All 
animals received humane care in compliance with the 
"Principle s of Laboratory Care" formulated by the Na- 
tional Society for Medical Research and with the '"Guide 
for Care and Use of Laboratory Animals" prepared by the 
National Academy of Sciences and published by the 
National Institutes of Health (NIH Publication No. 809- 
23, revised 1978). 
Biochemical analysis 
LDH andALP activity. Plasma LDH and ALP activities 
were detevmined on the day of experimentation. Plasma 
LDH was measured aecording to a modification of the 
procedure of  Wacker, Ulmer, and Vallee. 19 Plasma ALP 
was determined according to a modification of the method 
of Tietz. 2° 
XDH+XO. Plasma was stored at -85 ° C before analy- 
sis. Plasma samples were subjected to size exclusion I . 
chromatography wlth a G-25 column (Pharmacia, Piscat- 
away, N.J.) to remove low-molecular-weight inhibitors of 
XDH+XO. Total plasma XDH+XO activity was deter- 
mined by monitoring the production of uric acid in the 
presence o3 75/xmol/L xanthine and 0.5 mmol/L oxidized 
nicotinamideadenine dinucleotide. Allopurinol (100 /xmol/ 
L), an inhibitor of XDH+XO, was used in parallel assay 
samples toi confirm that urate formation was a result of 
XDH+XO activity. Oxonic acid (0.01 mmol/L) was added 
to inhibit t~ricase, an enzyme found in rabbits that oxidizes 
urate to alläntoin, to prevent underestimation of 
XDH+XO activity. After 60 minutes of incubation at 
37 ° C, the reaction was terminated by deproteinization. 
Deproteinized plasma was then assayed for uric acid with 
a high-performance liquid chromatography-based elec- 
trochemical technique developed by Tan and colleagues. 21 
Protein assay. Plasma and tissue samples were assayed 
for total protein concentration by a modification of the 
method of Smith and associates. 22Values obtained were 
used to determine original plasma XDH+XO activities by 
comparison of precolumn and postcolumn sample protein 
concentrations. 
Statistical analysis. All variables are expressed as 
mean plus or minus the standard error of the mean. The 
differences between the slopes of the regression lines in 
Figs. 1 and 2 (cumulative administration of Ringer's 
solution and phenylephrine) were compared by analysis of 
variance in which the hypothesis tested was the interaction 
of the group with time. Analysis of the total 2-hour 
cumulative dosage of all resuscitative interventions was 
conducted by a two-sample t test for independent samples 
with unequal variances. Analysis of the effect of ischemia- 
reperfusion on the release of circulating XDH+XO was 
conducted by repeated-measures analysis of variance. 
Comparison between groups for the change in plasma 
XDH+XO activity with each time point was done with 
use of the contrast statement of the repeated-measures 
analysis of variance. All analysis was done with SAS 
System for Personal Computers oftware, release 6.03 
(SAS Institute, Cary, N.C.). An alpha error of <0.05 was 
considered significant. 
Results 
Sham-operated rabbits administered a standard 
or tungstate-enriched diet did not require any phar- 
macologic interventions during the operative pe- 
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Fig. 2. Cumulative phenylephrine requirement was significantly decreased in aortic occlusion and 
reperfusion group pretreated with tungstate (AoOR+T) as compared with that in aortic occlusion and 
reperfusion group administered standard diet (AoOR). 
"C" 
..lE 
O" i i i  
E v 
i.u 
z 
O en 
r~ 
< 
O 
en 
Z 
30- 
20- 
10- 
• AoOR 
[ ]  AoOR+T 
p<0.001 
- - -V- -  
Fig. 3. Cumulative sodium bicarbonate requirement was 
significantly greater in aortic occlusion and reperfusion 
group administered standard diet (AoOR) as compared 
with that in aortic occlusion and reperfusion group pre- 
treated with tungstate (AoOR+T). 
riod, with the exception of the infusion of mainte- 
nance fluids. Plasma LDH and ALP activities did 
not change significantly over time in sham-operated 
animals. 
Ringer's solution administration (Fig. 1). The 
eumulative Ringer's solution requirement over time 
for rabbits in the aortic occlusion and reperfusion 
group pretreated with tungstate was significantly less 
during reperfusion as compared with that in those 
red a standard iet (p < 0.005). The total dosage of 
Ringer's solution during the 2 hours of reperfusion 
was greater in the aortic occlusion and reperfusion 
group red a standard iet (513 _+ 19 tal/kg) than that 
in those administered tungstate (370 __ 33 ml/kg, 
p < 0.005). 
Phenylephrine administration (Fig. 2). A 
marked reduction in cumulative phenylephrine r - 
quirements over time during reperfusion was ob- 
served in the rabbits pretreated with tungstate as 
compared with the requirement in those adminis- 
tered a standard iet (p = 0.0001). The total dosage 
of phenylephrine during the 2 hours of reperfusion 
was greater in the äortic occlusion and reperfusion 
group fed a standard iet (30 _+ 1.6 mg/kg) than that 
in the group administered tungstate (9.75 _+ 2.36 
mg/kg, p < 0.001). 
Sodium biearbonate administration (Fig. 3). 
Rabbits administered a standard iet required sig- 
nificantly more sodium bicarbonate (27.1 _+ 1.11 
mEq/kg) during the 2 hours of reperfusion thän 
animals pretreated with tungstate (18.9 -+ 1.05 mEq/ 
kg, p < 0.001). 
LDH and ALP activity (Figs. 4 and 5). Plasma 
LDH and ALP activity did not increase during the 
ischemic period in the aortic occlusion and reperfu- 
sion groups. However, LDH and ALP activity in- 
creased significantly (p < 0.05) during reperfusion 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 110, Number 3 
Nielsen et aL 719 
3000]/1 I A°OR 
l I- l AoOR« * 
• t 
1000 
0 BASELINE 40' 15' 30' 60' 120' 
ISCHEMIA 1__  REPERFUSlON - - t  
Fig. 4. LDH activity in plasma significantly increased during reperfusion in aortic occlusion and 
reperfusion group administered standard iet (AoOR) as compared with that in sham-operated rabbits 
(*p < 0.05). Pretreatment with tungstate significantly reduced plasma LDH activity in aortic occlusion and 
reperfusion group (AoOR+T) throughout 120 minutes of reperfusion (?p < 0.05). 
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Fig. 5. ALP activity in plasma significantly increased uring reperfusion i aortic occlusion and reperfu- 
sion group administered standard iet (AoOR) as compared with that in sham-operated rabbits (*p < 0.05). 
Pretreatment with tungstate significantly reduced plasma ALP activity in aortic occlusion and reperfusion 
group (AoOR+T) at 120 minutes of reperfusion (tp < 0.05). 
after thoracic aorta occlusion in both aortic occlu- 
sion and reperfusion groups as compared with val- 
ues in the sham-operated rabbits. The tungstate- 
pretreated aortic occlusion and reperfusion group 
had significantly less LDH release throughout the 
reperfusion period as compared with values in the 
aortic occ!usion and reperfusion group administered 
a standard iet (p < 0.05). Tungstate pretreatment 
significantly reduced ALP release at 2 hours of 
reperfusion (p < 0.05). 
XDH+XO aetivity (Fig. 6). Plasma XDH+XO 
activity in the aortic occlusion and reperfusion 
group administered a standard iet was increased 
significantly from a baseline value of 36 +- 5.5/zU/tal 
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Fig. 6. XDH+XO activity in plasma significantly increased uring reperfusion in aortic occlusion and 
reperfusion group administered standard iet (AoOR) as compared with that in sham-operated rabbits 
administered standard or tungstate-enriched diet (*p < 0.05). Pretreatment with tungstate significantly 
reduced XDH+XO activity in plasma of aortic occlusion and reperfusion group (AoOR+T) after 
descending thoracic aorta occlusion and reperfusion (?p < 0.05). 
to 678 _+ 213, 758 -+ 229, 1011 _+ 265, and 1085 ___ 
316 /xU/ml (mean _+ standard error of the mean) 
after 15, 30, 60, and 120 minutes of reperfusion, 
respectively (p < 0.001). Sham-operated animals 
pretreated with tungstate had significantly less 
plasma XDH+XO activity during experimentation 
than that observed in control animals administered 
a standard iet (p = 0.007). 
Discussion 
The concept that oxidants are involved in the 
pathophysiologic process of aortic deelamping in- 
jury is ¢ontroversial. Proposed mechanisms for the 
hemodynamic and metabolie disturbances observed 
after aortic declamping include vascular bed dilation 
in the ischemic area, 12 wash out of metabolic a¢ids 
into the systemic irculation, 12' 14 release of a pro- 
teinaceous "vasodepressor factor, ''s release of pros- 
taglandin E, 6 and free radical-mediated capillary 
membrane compromise. 7 Casthely and colleagues 7 
used a dog model of thoracic aorta crossclamping to
demonstrate improved hemodynamic status during 
declamping by administration of SOD. In contrast, 
Vo, Dunbar, and Stanton 23 documented no benefi- 
cial hemodynamic effects in a dog model of hemor- 
rhagic and declamping shock after administration of
either allopurinol (XDH+XO inhibitor) or SOD. 
These conflicting observations can be resolved by 
examination of the different methods used in these 
studies. Casthely's group crossclamped the descend- 
ing thoracic aorta for 1 hour and observed signifi- 
cant hemodynamic compromise at declamping in 
untreated animals. Vo's group occluded the distal 
abdominal aorta for 2 hours and reported minimal 
hemodynamic change at reperfusion in all experi- 
mental groups. If XO-derived oxidants contribute to 
declamping shock, one would expect o see a greater 
degree of hemodynamic aberration when tissues 
with high XDH+XO activity (such as liver and 
intestine) are reperfused, as was the case in the 
study by Casthely's group. Vo's group administered 
SOD (4 mg/kg) 15 minutes before reperfusion 
whereas Casthely's group infused SOD (15,000 
U/kg) just before reperfusion. The administered 
dosages of SOD are not comparable, and the circu- 
lating half life of SOD is reported to be 8 minutes by 
Turrens, Crapo, and Freeman. 24 It is thefefore likely 
that Casthely's group had a more efficacious SOD 
dosing regimen. Overall, the observations of both 
Casthely and colleagues 7 and the present study 
support he hypothesis that circulating oxidants play 
a significant role in the clinical manifestations of 
declamping shock after occlusion of the descending 
thoracic aorta. 
The present study supports the concept hat oxi- 
dants derived from circulating XDH+XO have a 
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significant impact on vasomotor tone during reper- 
fusion. The in vitro findings of Gao, Korthvis, and 
Benoit 2» are in agreement with our in vivo data. 
Those investigators demonstrated that aortic rings 
had a significantly reduced contractile response to 
norepinephrine in the presence of XDH+XO and 
xanthine. Removal of endothelium from the aortic 
rings did not decrease the contractile dysfunction. 
Administration of the XDH+XO inhibitor oxypuri- 
nol prevented the loss of constrictor responsiveness. 
These data are consistent with our observations that 
inactivation of circulating XDH+XO significantly 
reduced phenylephrine and Ringer's solution re- 
quirements. 
XO typically exists in an innocuous form (XDH) 
in nonischemic tissues, with purine catabolism oc- 
curring via reduction of nicotinamide-adenine dinu- 
cleotide. 26-3° However, if tissues are exposed to 
metabolic stress, such as hypoxia or ischemia, the 
enzyme converts to the oxidase form (XO) that can, 
in the presence of adequate substrate and molecular 
oxygen, generate the oxidants O2- and H202 .26-30 
Molybdenum is essential for XDH+XO activity, 
and substitution with tungstate will inactivate 
XDH+XO tissue activity. 26 Under normal condi- 
tions XDH+XO is substrate-limited because purine 
levels in the systemic irculation are only 1 to 3 
/xmol/L. 28 Liver and intestine have the greatest 
tissue activity of XDH+XO 26-2s and vascular endo- 
thelial cells contain the enzyme to a lesser ex- 
tent.29, 30 In human studies, an increase in plasma 
XO activity has been documented during reperfu- 
sion of an upper extremity undergoing an orthope- 
dic procedure. 31 Additionally, plasma concentra- 
tions of the XDH+XO substrates, hypoxanthine 
and xanthine, have been documented to increase 
after econstructive aortic operation. 32' 33 It is there- 
fore likely that XDH+XO and high concentrations 
of purine substrates could be released from reper- 
fused hepatic and intestinal tissues after descending 
thoracic aorta crossclamping. Ultimately, free radi- 
cal-mediated vascular endothelial cell injury could 
occur, leading to the clinical scenario f declamping 
shock and the release of cytosolic enzymes. 
During reperfusion, conversion of XDH to XO in 
plasma occurs within seconds 2s by several mecha- 
nisms, including rapid and reversible oxidation of 
sulfhydryls or irreversible proteolysis. 29Consequently, 
we report plasma ctivities as XDH+XO. Circulat- 
ing XO, in the presence of elevated levels of plasma 
purines, could cause oxidant-mediated issue injury. 
Endothelial cell injury may be further amplified by 
the release of chemoattractants and resultant neu- 
trophil-mediated damage, as seen in other animal 
models. 34 Inactivation of XDH+XO reduced sys- 
temic injury after aortic occlusion ~ ad reperfusion i
our rabbit model. A concurrent significant decrease 
in the release of ubiquitous q,tosolic enzymes 
(LDH, ALP) and a reduction in so~lium bicarbonate 
requirements was observed after tungstate pretreat- 
ment. These data suggest that XO ~»lays a major ole 
in the evolution of the oxidant-mediated microvas- 
cular injury that can ultimately lead to the scenario 
of multiple organ dysfunction orten seen after tho- 
racic aorta operations. 
In conclusion, we present a dinically relevant 
rabbit model of thoracic aorta oct lusion and reper- 
fusion and document a reduction in resuscitative 
requirements and systemic injury after inactivation 
of circulating XDH+XO activity. Although sodium 
tungstate administration is not a c!inically approved 
method of XDH+XO inactivation, a similar reduc- 
tion in postocclusion shock and systemic injury may 
be realized by inhibition of circulating XDH+XO 
with clinically available medicatiGns (for example, 
allopurinol). 
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